| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |